Total Funding
49
61
Total FundingPost-IPO Debt raised
Growth Score
-14 pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
55139
Cryoport provides a complete, outsourced, frozen shipping solution for biological materials.
Jerrell W. Shelton: President and Chief Executive OfficerPast Role: IBM Research, Visiting Executive
Robert S. Stefanovich: SVP, Chief Financial Officer & TreasurerPast Role: Novalar Pharmaceuticals, Chief Financial Officer
About the Company
Cryoport delivers an innovative and complete outsourced frozen shipping solution for biological materials.
This breakthrough combination replaces outdated dry ice shipping, virtually eliminates the risk of cell degradation and revolutionizes deep frozen logistics. We combine the technology of liquid nitrogen dry vapor shippers with the most
advanced Logistics Management Platform in the industry. When added with our logistics expertise, we provide a complete outsourced solution that advances deep-frozen shipping for the life science community.
Whether your business is bio-pharmaceuticals, clinical trials, research or reproductive medicine, you want to focus on your core mission. Cryoport will help you transport life.
